DexCom, Inc. (DXCM)

Healthcare · Price $81.61 (close, 2026-11-16) · Engine scoring-engine-v1.5

Beta 1.44 · P/E (trailing) 32.13 · Market cap $31.8B · Debt/FCF 1.27× · Rel. vol 0.88× · Index S&P 500 + Nasdaq-100

How to read this card ↓

AvoidOverall score 58.9

Avoid gate: valuation score 26.4 < 30; price $81.61 at/above our Exit $74.77

Fair value$62.31
Price vs fair value-23.6%

Score pillars

Conviction57.0
Valuation26.4
Quality89.0
Technical70.8
Trust79.0

Conviction

Story62.7
Financials51.3

Quality

CheckScore
OCF vs net income100.0
Accruals (Sloan)100.0
Receivables trend70.0
FCF conversion100.0
Return on assets55.0
Leverage80.0
OCF as % of net income+142.7%
Accruals (Sloan)-0.0953
Receivables change+1.15 pp
FCF conversion+110.8%
Return on assets+11.1%
Debt / equity0.55

Technical

CheckScore
EMA trend60.0
Price vs 200-day75.0
RSI80.0
MACD75.0
EMA 20$82.24
EMA 50$83.10
EMA 200$76.80
RSI (14)47.9
MACD histogram0.16
Price vs 200-day+6.3%

Trust

CheckScore
Data completeness100.0
Analyst coverage80.0
Target dispersion80.0
Insider activity45.0
Analysts covering26
Target spread ÷ mean0.416
Insider activity (90d)8 sales, 49,578 shares, $4M, 0 buys in 90d

Valuation

Fair value$62.31
Price$81.61
Upside vs price-23.6%
Leg spread ÷ fair value+33.7%

DCF leg

$77.99

PEGY leg

$62.31Fair value

PEGY 0.763

Forward-sector leg

$57.00

Sector forward P/E 20.0× (as of 2026-11-13)

Valuation ladder

Heavy
$37.39
Buy
$49.85
Fair
$62.31
Exit
$74.77
← price here

Price $81.61 vs fair value $62.31 — the price sits above the Exit rung. The ladder is valuation context — where the price sits against our fair-value estimate — not a buy or sell signal. Backtests on 5 tickers and on the full 749-name universe found the ladder does not separate forward returns (see Methodology). No level on this ladder is an instruction to buy or sell.

CAPM cross-check — display only

CROSS-CHECK ONLY — does not change any fair value, score or verdict.

CAPM DCF value $69.75 at a CAPM discount of +10.8%, vs the decision DCF leg of $77.99.

CAPM discount+10.8%
Raw beta (Yahoo)1.443
Adjusted beta1.297
10-year Treasury5.10% as of 2026-11-12 (FRED DGS10)
Implied ERP4.41% as of 2026-11-01

Backtest v3 (full 749-name universe) measured the effect of the CAPM leg: 6-month correlations were about −0.06 vs −0.05 for flat discounts, and the buckets still do not separate forward returns — so the leg stays display-only.

DCF sensitivity grid

At 20% growth × 5.0% risk-free rate, the DCF leg is $77.99 — the decision leg .

FCF growth ↓ / rf →4.0%4.5%5.0%5.5%6.0%
0%$39.87$37.06$34.62$32.49$30.60
5%$49.51$45.93$42.83$40.12$37.73
10%$61.04$56.54$52.64$49.23$46.22
15%$74.74$69.13$64.28$60.03$56.29
20%$90.91$83.98$77.99$72.75$68.14

The highlighted cell is this stock's published DCF value: $77.99. Click any cell to compare it with the decision leg. Cells are shaded by value across this grid's own range — greener is a higher DCF leg, redder is lower.

Each row is a different growth assumption; each column is a different risk-free rate. The highlighted cell is this stock's published DCF value.

Earnings-quality evidence

Quality score 89.0 — OCF +142.7% of net income, FCF conversion +110.8% of net income, accruals (Sloan) -0.0953, receivables change +1.15 pp, return on assets +11.1%, debt / equity 0.55.

No one-off earnings adjustment was applied to this name.

Pros

  • Revenue compounded 17% a year over the last 3 fiscal years.
  • Operating cash flow is 143% of net income — profit is backed by more cash than earnings.
  • Accruals are low/negative (Sloan) — earnings quality looks clean on that check.
  • Free-cash-flow conversion is strong: FCF is 111% of net income.

Cons

  • Fair value $62.31 is -24% below the $81.61 price — even the most generous leg ($77.99) sits below the price.
  • Insiders are net sellers — 8 sales, 49,578 shares, $4M, 0 buys in 90d.

The Stock Check vs Wall Street

The Stock CheckWall Street (analyst consensus)
Fair value / mean target$62.31$98.58
Implied upside vs price-23.6%+20.8%
Target range (low – high)—$79.00 – $120.00
Analysts covering—26
Gap vs consensus mean−$36.27 (-36.8%)

Why the gap?

No leg sits close to the consensus mean: the closest leg, DCF at $77.99, is still 20.9% from the $98.58 consensus mean, while our fair value is $62.31 — the gap is not explained by the legs.

Analyst consensus: Yahoo Finance analyst targets, fetched 15–16 Nov 2026. Targets are carried through unchanged from that frozen fetch; the nightly refresh updates price only.

Flags

One-off check: 2 of 4 TTM quarters showed unusually large earnings moves (flag only — no adjustment applied).

What is not here yet

Price chart, financials table, news and dividends are not in this build's data yet. The price ($81.61) and the technicals above are the current snapshot — the 2026-11-16 close after hours, live during market hours; those sections arrive with the live-data feed.

How to read this card

Fair value and the three legs

Fair value. Our single fair-value estimate for the stock, drawn from the three legs below. If the price is well below it, the stock looks cheap on our numbers. If it is well above it, the stock looks expensive — and a wide gap between the legs means more uncertainty.

DCF leg. What the stock could be worth based only on the cash the business is expected to generate in the years ahead. A higher number means that future cash looks more valuable. Compare it with the other two legs — if they disagree a lot, treat the fair value with more caution.

PEGY leg. What the stock could be worth based on its earnings, how fast those earnings are expected to grow, and the dividend it pays. A higher number means the stock looks cheaper against its growth. Compare it with the other two legs before judging the fair value.

Forward-sector leg. What the stock could be worth based on next year's expected earnings, priced the way the market currently prices its sector. A higher number means the stock looks cheaper against next year's earnings. Compare it with the other two legs before judging the fair value.

The five scores

Conviction. How strong the company's story and financials look — whether the business is growing and gaining ground. A higher score means a stronger business story. It says nothing about whether the stock is cheap.

Quality. Whether the reported profits are backed by real cash, rather than accounting that flatters the numbers. A higher score means the earnings look more solid. A low score means you should trust the profit figures less.

Technical. Whether the price trend and momentum are with the stock right now. A higher score means the short-term trend looks stronger. It says nothing about the business itself.

Trust. How much we can rely on the numbers behind the score — whether the data is complete and well covered. A higher score means the figures rest on firmer ground. A lower score means more of the picture is missing or disputed.

Valuation score. How cheap or expensive the stock looks against our fair value — the bigger the upside to fair value, the higher the score. A high score means the price sits well below our fair value. A low score means it sits at or above it.

The ladder and the grid

Valuation ladder. Four price levels around our fair value, showing where today's price sits against our estimate. Read them as reference points for judging how far the price is from our estimate. They are not instructions to trade.

DCF sensitivity grid. The same DCF leg, shown under different assumptions instead of a single point — so you can see how much the answer moves if the future turns out differently. The highlighted cell is this stock's own estimate. Cells further away show how the value would change if growth or rates came in higher or lower.

The comparison and CAPM

The Stock Check vs Wall Street. Our fair value next to Wall Street's — the average of the price targets published by the analysts who cover the stock. If our number is well above theirs, we are more optimistic than the average analyst. If it is well below, we are more cautious.

CAPM cross-check. A second, independent check on the DCF leg, built from market inputs. It never changes the fair value, score or verdict. If it lands close to the DCF leg, the two views agree. If it lands far away, treat the DCF leg with more caution.

Full detail: Methodology.

Data as of 2026-11-16 · scoring-engine-v1.5 · Prices are the 2026-11-16 close unless marked LIVE during market hours (quotes delayed ~15 min, TradingView).